** Shares of Novanta Inc NOVT.O, precision technology provider for medical and advanced industrial applications, down 6% premarket at $124.53 as it seeks capital raise
** Bedford, Massachusetts-headquartered NOVT late Weds commenced offering of 11 mln 3-year mandatory convertible tangible equity units for $550 mln
** Co intends to use portion of net offering proceeds to repay approx $317 mln of indebtedness under its revolver, and for working capital and potential acquisitions, among other uses
** JP Morgan and BofA are joint bookrunners
** NOVT, which is incorporated in Canada, has ~35.78 mln shares outstanding for $4.7 bln market cap as of Weds
** Late Mon, NOVT said Q3 rev grew 1.4% y/y to $247.8 mln and posted adj EPS of 87 cents vs 85 cents a year ago
** Through Weds close, shares gained about 27% over the past month, leaving them down 13% YTD
** 2 analysts rate NOVT "strong buy" or "buy", 2 others rate "hold"; median PT is $158.50, per LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))